CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 48,688 Value ($000) $204 Avg Close Range
Q4 2022
Shares 48,688 Value ($000) $293 Avg Close Range
Q3 2022
Shares 48,688 Value ($000) $283 Avg Close Range
Q2 2022
Shares 48,688 Value ($000) $291 Avg Close Range
Q2 2018
Shares 27,473 Value ($000) $137 Avg Close Range